Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC ...Middle East

Medscape - News
The novel drug appears to be effective for patients with EGFR-mutated NSCLC that has a hard-to-treat exon 20 insertion after disease progression with platinum-based chemotherapy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Amivantamab Shows Promise in Challenging EGFR-Mutated NSCLC )

Apple Storegoogle play

Also on site :

Most viewed in News